Gut hormones of preterm infants with abdominal symptoms and hypothyroxinemia

Ryou Kawamata1, Yume Suzuki1, Yukari Yada1

  • 1Department of Pediatrics, Jichi Medical University School of Medicine, Shimotsuke, Tochigi, Japan.

Insights

Thyroid hormone levels in preterm infants affect gut hormones. Supplementation with levothyroxine sodium (T4-Na) normalized levels of glucagon-like peptide-1 (GLP-1), glucose-dependent insulinotropic polypeptide (GIP), and peptide YY (PYY), resolving abdominal symptoms.

Area of Science:

  • Neonatalogy
  • Endocrinology
  • Gastroenterology

Background:

  • Abdominal symptoms in preterm infants with hypothyroxinemia lack clear pathogenesis.
  • Thyroid hormone deficiency may impact gastrointestinal function in neonates.

Purpose of the Study:

  • To investigate the relationship between hypothyroxinemia and gut hormone levels in preterm infants.
  • To assess the effect of levothyroxine sodium (T4-Na) supplementation on gut hormone concentrations and abdominal symptoms.

Main Methods:

  • Measured fasting serum concentrations of multiple gut hormones (leptin, GIP, GLP-1, PYY, etc.) in preterm infants and controls using a bead array system.
  • Compared hormone levels before and after T4-Na supplementation in infants with abdominal symptoms.

Main Results:

  • Preterm infants with hypothyroxinemia and abdominal symptoms had lower serum levels of GLP-1, GIP, and PYY compared to controls.
  • Following T4-Na supplementation and symptom improvement, these gut hormone levels increased significantly.
  • Post-supplementation hormone levels in the infant group normalized to those of the control group.

Conclusions:

  • Serum levels of GLP-1, GIP, and PYY are potentially linked to thyroid function in preterm infants.
  • Thyroid hormone status may play a role in regulating gut hormone secretion and gastrointestinal function in neonates.
Abstract

Related Concept Videos

Hypothyroidism II: Pathophysiology01:23

Hypothyroidism II: Pathophysiology

Hypothyroidism is a disorder characterized by insufficient production of thyroid hormones, which regulate metabolism, energy balance, and multiple organ systems.TypesHypothyroidism is classified based on the level of dysfunction. Primary hypothyroidism results from intrinsic thyroid gland dysfunction, causing reduced hormone production despite normal or increased stimulation. Secondary hypothyroidism arises from inadequate thyroid-stimulating hormone (TSH) secretion by the pituitary. Tertiary...
7
Synthesis and Regulation of Thyroid Hormones01:20

Synthesis and Regulation of Thyroid Hormones

Low blood levels of the thyroid hormones — triiodothyronine (T3) and thyroxine (T4) — signal the hypothalamus to release the thyrotropin-releasing hormone (TRH). TRH then reaches the pituitary gland and stimulates the release of thyroid-stimulating hormone(TSH) into the bloodstream.
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The...
9.5K
Hyperthyroidism I: Introduction01:25

Hyperthyroidism I: Introduction

Hyperthyroidism is a type of thyrotoxicosis characterized by the thyroid gland's overproduction of the thyroid hormones triiodothyronine (T3) and thyroxine (T4). This hormone excess increases the basal metabolic rate and enhances sensitivity to catecholamines.DiagnosisDiagnosis is based on clinical features and biochemical testing. It typically shows suppressed thyroid-stimulating hormone (TSH) levels below 0.4 mIU/L, with elevated free T3 and/or T4. Additional tests, including thyroid...
6
Hyperthyroidism II: Pathophysiology01:27

Hyperthyroidism II: Pathophysiology

Hyperthyroidism is a hypermetabolic state caused by elevated levels of thyroid hormones, triiodothyronine (T3) and thyroxine (T4). It results from dysregulation at the thyroid, pituitary, or immune system level and affects multiple organ systems.PathophysiologyThe most common cause of hyperthyroidism is Graves’ disease, an autoimmune disorder in which antibodies, specifically thyroid-stimulating antibodies (TSAb), a subtype of TSH receptor antibodies (TRAb), bind to and activate TSH...
7
Graves Disease II: Pathophysiology01:24

Graves Disease II: Pathophysiology

Graves’ disease is an autoimmune disorder characterized by the production of thyroid-stimulating immunoglobulins (TSI) that activate TSH receptors, leading to excessive synthesis and release of thyroid hormones (T3 and T4) and resulting in hyperthyroidism.Among all causes of hyperthyroidism, Graves’ disease is the most common and can happen at any age, though it is more frequent in women. It produces a hypermetabolic state with features such as weight loss, tachycardia, tremor,...
7
Functions of Thyroid Hormones01:18

Functions of Thyroid Hormones

The thyroid hormone (TH) plays a pivotal role in the intricate orchestration of physiological processes, exerting profound effects on development, metabolism, and homeostasis throughout different life stages.
TH is indispensable for the normal development and maturation of the skeletal, muscular, and nervous systems during fetal and childhood growth. It facilitates bone mineral turnover and regulates protein synthesis in developing tissues, contributing significantly to overall growth and...
7.1K